Cargando…

A retrospective study of antipsychotic drug switching in a pediatric population

BACKGROUND: Antipsychotic drugs can be used to help treat a wide variety of psychiatric disorders. However, specific antipsychotic drugs for any particular patient may need to be changed for a number of different reasons, including a lack of therapeutic efficacy and / or intolerance to medication si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Linton, David, Procyshyn, Ric M, Elbe, Dean, Lee, Lik Hang N, Barr, Alasdair M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851439/ https://www.ncbi.nlm.nih.gov/pubmed/24103197 http://dx.doi.org/10.1186/1471-244X-13-248

Ejemplares similares

Population pharmacokinetics and dosing of long-acting injectable antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Antipsychotic prescribing patterns on admission to and at discharge from a tertiary care program for treatment-resistant psychosis
por: Lee, Lik Hang N., et al.
Publicado: (2018)

Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review
por: Yin, John, et al.
Publicado: (2017)

Association between Serum Lipids and Antipsychotic Response in Schizophrenia
por: Kim, David D., et al.
Publicado: (2019)

A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
por: Boyda, Heidi N., et al.
Publicado: (2021)

Long-acting injectable antipsychotics for early psychosis: A comprehensive systematic review
por: Lian, Lulu, et al.
Publicado: (2022)

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines
por: Boyda, Heidi N., et al.
Publicado: (2020)

Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance
por: Boyda, Heidi N., et al.
Publicado: (2022)

M216. ASSOCIATIONS OF EXTRAPYRAMIDAL SYMPTOMS WITH PSYCHOTIC SYMPTOMS IN A COHORT OF HOMELESS OR PRECARIOUSLY HOUSED PERSONS WITH OR WITHOUT SCHIZOPHRENIA
por: Kim, David, et al.
Publicado: (2020)

Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
por: Boyda, Heidi N., et al.
Publicado: (2013)

Developing prediction models for symptom severity around the time of discharge from a tertiary-care program for treatment-resistant psychosis
por: Lee, Lik Hang N., et al.
Publicado: (2023)

An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
por: Wu, Claire, et al.
Publicado: (2014)

Exercise and Worsening of Extrapyramidal Symptoms during Treatment with Long-Acting Injectable Antipsychotics
por: Kim, David D., et al.
Publicado: (2021)

Management of Medication-Related Cardiometabolic Risk in Patients with Severe Mental Illness
por: Lang, Donna J., et al.
Publicado: (2013)

Stopping and switching antipsychotic drugs
por: Keks, Nicholas, et al.
Publicado: (2019)

A systematic review of the effects of CYP2D6 phenotypes on risperidone treatment in children and adolescents
por: Dodsworth, Thomas, et al.
Publicado: (2018)

Housing First Improves Adherence to Antipsychotic Medication Among Formerly Homeless Adults With Schizophrenia: Results of a Randomized Controlled Trial
por: Rezansoff, Stefanie N., et al.
Publicado: (2017)

A Focused Review of the Metabolic Side-Effects of Clozapine
por: Yuen, Jessica W. Y., et al.
Publicado: (2021)

Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
por: Yuen, Jessica W. Y., et al.
Publicado: (2018)

Antipsychotic switching tool
por: Keks, Nicholas, et al.
Publicado: (2019)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

Efficacy and tolerability of aripiprazole versus D(2) antagonists in the early course of schizophrenia: a systematic review and meta-analysis
por: Kim, David D., et al.
Publicado: (2021)

Antipsychotic switching tool [Update]
Publicado: (2019)

Antidepressant and antipsychotic use in an Italian pediatric population
por: Clavenna, Antonio, et al.
Publicado: (2011)

Undetectable or subtherapeutic serum levels of antipsychotic drugs preceding switch to clozapine
por: Kyllesø, Lennart, et al.
Publicado: (2020)

Characterization of mental health in cannabis dispensary users, using structured clinical interviews and standardized assessment instruments
por: Yau, Jade C., et al.
Publicado: (2019)

Antipsychotic switching tool [Update 2]
Publicado: (2020)

Antipsychotic switching tool [Update 3]
Publicado: (2021)

Antipsychotic switching tool [Update 4]
Publicado: (2022)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Pharmacy switch of antipsychotic medications: patient’s perspective
por: Murawiec, Slawomir, et al.
Publicado: (2015)

A case of postpsychotic depression improved by switching antipsychotic monotherapy
por: Oguchi, Yoshiyo, et al.
Publicado: (2022)

Clinical and economic ramifications of switching antipsychotics in the treatment of schizophrenia
por: Faries, Douglas E, et al.
Publicado: (2009)

Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations
por: Sagreiya, Hersh, et al.
Publicado: (2017)

The Influence of Previous Antipsychotic Polypharmacy Versus Monotherapy on the Effectiveness of Antipsychotic after Switching to Paliperidone Extended-release
por: Lee, Hee-Won, et al.
Publicado: (2013)

Novel Antipsychotic Drugs
por: Krystal, John H.
Publicado: (1992)

The development of antipsychotic drugs
por: Cunningham Owens, David, et al.
Publicado: (2018)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2021)

Personalized Risk Assessment of Drug-Related Harm Is Associated with Health Outcomes
por: Jones, Andrea A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s6kqjcvqg47gvne644kjl6suth